Skip to main
  1. Stocks
  2. Filana Therapeutics Inc
  3. P/E Ratio
FLNA

FLNA P/E Ratio

P/E Ratio as of Nov 9, 2026: -0.56

Average-0.7267
Median-0.7400
Minimum-0.8800
Maximum-0.5200
-0.56
0.37 (39.78%)past month
The P/E ratio for FLNA is -0.56 as of Nov 9, 2026. This represents a decrease of -41.67% compared to its 12-month average P/E ratio of -0.96. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Filana Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Filana Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Filana Therapeutics Inc to industry peers.

FLNA P/E Ratio Insights

See Filana Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.

Start investing in FLNA

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FLNA P/E Ratio Historic Data

DateStock priceP/E ratio
Nov 2, 2026$0.561-0.64
Oct 1, 2026$0.965-1.10
Sep 1, 2026$0.8573-0.98
Aug 3, 2026$1.03-1.18
Jul 1, 2026$1.25-0.78
Jun 1, 2026$1.49-0.92
May 1, 2026$1.51-0.80
Apr 1, 2026$1.72-0.91
Mar 2, 2026$2.32-1.06
Feb 2, 2026$1.94-0.88
Jan 2, 2026$2.09-0.95

FLNA End of Year P/E Ratio

DateP/E ratioChange
2026-0.56-37.78%
2025-0.90-47.67%
2024-1.72-82.48%
2023-9.82-40.77%
2022-16.58-69.05%
2021-53.57—

FAQs About Filana Therapeutics Inc (FLNA) P/E ratio

The latest P/E ratio of FLNA is -0.56, as of Nov 9, 2026. This is calculated based on its current stock price and earnings per share (EPS).

Filana Therapeutics Inc’s last 12-month average P/E ratio is -0.96, compared to its current P/E ratio of -0.56. This reflects a decrease of -41.67%.

Filana Therapeutics Inc’s current P/E ratio of -0.56 is lower than its last 12-month average P/E of -0.96. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Filana Therapeutics Inc’s average P/E ratio over the last 3 years is -5.07. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Filana Therapeutics Inc’s average P/E ratio over the last 5 years is -12.39. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Filana Therapeutics Inc (FLNA)


FLNA P/E Ratio Insights

See Filana Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.

Start investing in FLNA

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover FLNA stock data and trends